Invention Grant
- Patent Title: Bromide source for use in treating autism spectral disorder
-
Application No.: US16464403Application Date: 2017-11-28
-
Publication No.: US11666599B2Publication Date: 2023-06-06
- Inventor: Sébastien Roux , Thierry Plouvier , Julie Le Merrer , Jérôme Becker
- Applicant: INSERM, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE , INRA, INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE , CNRS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE , UNIVERSITE DE STRASBOURG
- Applicant Address: FR Paris
- Assignee: INSERM, INTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE,INRA, INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE,CNRS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE,UNIVERSITE DE STRASBOURG
- Current Assignee: INSERM, INTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE,INRA, INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE,CNRS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE,UNIVERSITE DE STRASBOURG
- Current Assignee Address: FR Paris; FR Paris; FR Paris; FR Strasbourg
- Agency: WCF IP
- Priority: GB 20095 2016.11.28
- International Application: PCT/EP2017/080726 2017.11.28
- International Announcement: WO2018/096184A 2018.05.31
- Date entered country: 2019-05-28
- Main IPC: A61K33/00
- IPC: A61K33/00 ; A61P25/00 ; A61K31/522
Abstract:
The present invention relates to a novel pharmaceutical use of bromide, i.e. the treatment of autism spectral disorder (ASD).
Public/Granted literature
- US20210106613A1 BROMIDE SOURCE FOR USE IN TREATING AUTISM SPECTRAL DISORDER Public/Granted day:2021-04-15
Information query
